![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1308702
½º¸¶Æ® ÀÇ·á±â±â ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç° À¯Çü, ¸ð´Þ¸®Æ¼, À¯Åë ä³Î, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¼¼°è ºÐ¼®Smart Medical Devices Market Forecasts to 2030 - Global Analysis By Product Type, Modality, Distribution Channel, Technology, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ½º¸¶Æ® ÀÇ·á±â±â ½ÃÀåÀº 2023³â¿¡ 469¾ï ´Þ·¯¸¦ Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ Áß CAGRÀº 22.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 1,886¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
¿þ¾î·¯ºíÀº º´¿ø ħ´ë³ª °³ÀÎ °¡Á¤¿¡¼ Áß¿äÇÑ ÀÇ·á µ¥ÀÌÅ͸¦ ½Ç½Ã°£À¸·Î Àü´ÞÇØ ȯÀÚ¿Í Àǻ縦 ¿¬°áÇÏ´Â µ¥ µµ¿òÀÌ µÉ »Ó¸¸ ¾Æ´Ï¶ó, ÀÀ±Þ ÇöÀåÀ̳ª ¿î¼Û Â÷·®¿¡¼ »ç¿ëµÇ´Â ¸ð¹ÙÀÏ ±â¼úÀ̱⵵ ÇÕ´Ï´Ù. ȯÀÚ µ¥ÀÌÅÍ´Â ½º¸¶Æ® ±â¼úÀÌ µîÀåÇϱâ ÈξÀ ÀüºÎÅÍ ¼öÁýµÇ¾î ¿ÔÁö¸¸, ½º¸¶Æ® ÀÇ·á±â±âÀÇ µµÀÔÀ¸·Î ÀÇ·á Àü¹®°¡µéÀÌ È¯ÀÚ µ¥ÀÌÅ͸¦ ¼öÁýÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.
À¯¿£ Àα¸ ±â±Ý¿¡ µû¸£¸é ÀÌ Áö¿ªÀº ¼¼°è Àα¸ÀÇ 43¾ï ¸í ÀÌ»ó¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹½ÉÀåÇùȸ 2021, ½ÉÀ庴 ¹× ³úÁ¹Áß Åë°è ¾÷µ¥ÀÌÆ® ÆÑÆ® ½ÃÆ®¿¡ µû¸£¸é °ü»óµ¿¸Æ ½ÉÀ庴(CHD)Àº ¹Ì±¹¿¡¼ ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÇ ÁÖ¿ä ¿øÀÎ(42.1%)À̾ú½À´Ï´Ù.
½ÃÀå ÅõÀÚ È®´ëµµ ÀÌ ºÐ¾ß°¡ ´õ¿í °·ÂÇÑ ¼ºÀå ±Ëµµ¸¦ ±¸ÃàÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ß¿¡´Â Å« º¯È°¡ ÀϾ°í ÀÖÀ¸¸ç, ±× Áß ¸¹Àº ºÎºÐÀÌ ±àÁ¤ÀûÀ̶ó°í ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿©±â¼ ¾ð±ÞµÈ °¡Àå Áß¿äÇϰí À¯ÀÍÇÑ °á°ú Áß Çϳª´Â ±â¼úÀÇ ¹ßÀüÀÔ´Ï´Ù. ±× ÀáÀçÀû ÀÌÁ¡Àº Çì¾Æ¸± ¼ö ¾øÀ» Á¤µµ·Î ¸¹À¸¸ç, ÀÌ·¯ÇÑ Ç³ºÎÇÔÀº ½º¸¶Æ® ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ÀÇ·á ¼º°ú¸¦ Çâ»ó½Ã۱â À§ÇÑ ³ë·ÂÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÅÈï ±¹°¡ ¹× Àú¼Òµæ ±¹°¡ÀÇ °æ¿ì ÀûÀýÇÑ Àü±â ÀÎÇÁ¶ó°¡ ±¸ÃàµÇ¾î ÀÖÁö ¾Ê¾Æ ½º¸¶Æ® ÀÇ·á±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù. ÃֽŠÀÇ·á±â±â´Â Àü·ÂÀ» ±â¹ÝÀ¸·Î ÇÏ´Â IT Çϵå¿þ¾î¿Í ¼ÒÇÁÆ®¿þ¾î¿¡ Å©°Ô ÀÇÁ¸Çϱ⠶§¹®¿¡ ½ÅÈï ±¹°¡¿¡¼´Â ÇコÄÉ¾î ¾÷¹«¿¡ ¿µÇâÀ» ÁÖÁö ¾Ê°í ½º¸¶Æ® ÀÇ·á±â±â¸¦ ÅëÇÕÇÒ ¼ö ¾ø½À´Ï´Ù. µû¶ó¼ Á¤ÀüÀ̳ª Àü·Â °ø±Þ Á¦ÇÑÀº ½º¸¶Æ® ±â±âÀÇ ÀÛµ¿À» À§Çè¿¡ ºü¶ß¸± ¼ö ÀÖ½À´Ï´Ù.
¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çö»óÀº ´Ù¾çÇÑ »ýȰ½À°üÀÇ º¯È¿Í °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¿îµ¿ ºÎÁ·, ºÒ±ÔÄ¢ÇÑ ½Ä½À°ü, Èí¿¬, À½ÁÖ ¹× ±âŸ °Ç°¿¡ ÇØ·Î¿î ½À°üÀÌ ±× Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ½ºÆ®·¹½º ¼öÁØÀÌ ÇöÀúÇÏ°Ô Áõ°¡ÇÏ¿© ´Ù¾çÇÑ °Ç° »óÅÂÀÇ ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °·ÂÇÑ ÀÇ·á ½Ã½ºÅÛ°ú À¯¸®ÇÑ ÁöºÒ Á¤Ã¥À» °¡Áø ¼±Áø±¹ÀÎ ¹Ì±¹¿¡¼´Â ¸¸¼ºÁúȯÀÌ ¸Å¿ì ÈçÇÏ°Ô ¹ß»ýÇÕ´Ï´Ù. ½º¸¶Æ® ÀÇ·á±â±â ¼¼°è ½ÃÀåÀ» ÃËÁøÇÏ´Â ¶Ç ´Ù¸¥ ¿äÀÎÀº ÇÇÆ®´Ï½º Æ®·»µå Áõ°¡ÀÔ´Ï´Ù. ´Þ¸®±â, ½ºÆ÷Ã÷ µî °Ç°À» À§ÇØ ¸öÀ» ¿òÁ÷ÀÌ´Â »ç¶÷µéÀÌ ´Ã¾î³ª¸é¼ ½º¸¶Æ® ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÇ·á±â±âÀÇ »ç¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½º¸¶Æ® ÀÇ·á±â±âÀÇ °¡°ÝÀÌ ºñ½Ñ °ÍÀº ±× ±â¼ú·ÂÀÌ ³ô±â ¶§¹®ÀÔ´Ï´Ù. ´ëºÎºÐÀÇ ÁßÀú¼ÒµæÃþÀº ÀÌ·¯ÇÑ ±â¼úÀ» ±¸¸ÅÇÒ ¿©·ÂÀÌ ¾ø¾î Á¢±ÙÇϱ⠾î·Á¿î »óȲÀÔ´Ï´Ù. ½º¸¶Æ® ÀÇ·á±â±âÀÇ ³ôÀº ºñ¿ëÀº ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÇÁ¶óÀ̹ö½Ã ¹®Á¦´Â ½ÃÀå ¼ºÀåÀ» ´õ¿í Á¦ÇÑÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
COVID-19´Â ½º¸¶Æ® ÀÇ·á±â±â ±â¾÷¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Äڷγª¹ÙÀÌ·¯½º°¡ µµÀÔµÈ ÀÌÈÄ ¼¼°è ´ëºÎºÐÀÇ Áö¿ª¿¡¼ ¸¹Àº Ä¿¹Â´ÏƼ ¼¾ÅÍ ¹× ±âŸ ÇÇÆ®´Ï½º Á¶Á÷ÀÌ È°µ¿À» Áß´ÜÇß½À´Ï´Ù. ÀÌ·Î ÀÎÇØ »ç¿ëÀÚµéÀº µðÁöÅÐ ¹× ±âŸ ¾Û ±â¹Ý ¼Ö·ç¼ÇÀ» »ç¿ëÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ Àΰ£ÀÇ »ýü ½ÅÈ£¸¦ ÃßÀûÇÏ°í ¸ð´ÏÅ͸µÇÏ´Â AI ±â¹Ý ÀÇ·á±â±â¿¡ ´ëÇÑ Àνİú ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î Àεµ¿¡¼´Â Max Healthcare¿Í MyHealthcare°¡ 2021³â 6¿ù¿¡ ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°ú ¿¬°áµÈ AI ±â¹Ý ±â±â¸¦ Ãâ½ÃÇÒ ¿¹Á¤ÀÔ´Ï´Ù.
Àν¶¸° ÆßÇÁ´Â ´ç´¢º´ ȯÀÚ¿¡°Ô Àν¶¸°À» °ø±ÞÇÏ´Â ÀÇ·á±â±âÀ̱⠶§¹®¿¡ ¿¹Ãø ±â°£ Áß Ä¡·á ±â±â ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àν¶¸° ÆßÇÁ´Â ÆßÇÁ, ÀÏȸ¿ë ÀúÀå¼Ò, ÀÏȸ¿ë ÁÖÀÔ ¼¼Æ®ÀÇ ¼¼ ºÎºÐÀ¸·Î ±¸¼ºµË´Ï´Ù. ÆßÇÁÀÇ ºÎǰÀº ÄÁÆ®·Ñ·¯, ó¸® ¸ðµâ ¹× ¹èÅ͸®·Î ±¸¼ºµË´Ï´Ù. ÆßÇÁ ³»ºÎ¿¡´Â ÀÏȸ¿ë ÀúÀå¼Ò°¡ Àν¶¸°À» ÀúÀåÇÕ´Ï´Ù. ±×·¯³ª ij´¼¶ó¿Í Àν¶¸° ÀúÀå¼Ò¸¦ ij´¼¶ó·Î ¿¬°áÇϱâÀ§ÇÑ Æ©ºê ½Ã½ºÅÛÀÌ ÀÏȸ¿ë ÁÖÀÔ ¼¼Æ®¸¦ ±¸¼ºÇÕ´Ï´Ù. Àν¶¸° ÆßÇÁ´Â ÈÞ´ë°¡ °¡´ÉÇÏ°í °ø±ÞµÇ´Â Àν¶¸°ÀÇ Á¤È®ÇÑ ¾çÀ» ÃøÁ¤ÇÏ¿© ¿ë·® ³¶ºñ¸¦ ÁÙÀ̰í ȯÀÚ¿¡°Ô Á¤È®ÇÑ Àν¶¸° °ø±ÞÀ» º¸ÀåÇÕ´Ï´Ù.
½ÉÇ÷°ü Ä«Å×°í¸®´Â ´ç´¢º´°ú °°Àº ½ÉÇ÷°ü Áúȯ Áõ°¡¿Í ÀÇ·á±â±â ¿¬±¸ ºñ¿ëÀÇ ±ÞÁõÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGR·Î ¹ßÀüÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ½º¸¶Æ® ÀÇ·á±â±âÀÇ »ç¿ë Áõ°¡´Â ±â±â ¿ëµµ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ±â¿©ÇÏ¿© ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í·ÉÈ Àα¸ Áõ°¡, ±â¼ú ¹ßÀü, ½º¸¶Æ® ÀÇ·á±â±âÀÇ È¿°ú·Î ÀÎÇØ ½ÉÇ÷°ü ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Ãß¼¼´Â ¿¹Ãø ±â°£ Áß Áö¼ÓµÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ºÏ¹ÌÀÇ ÀÇ·á ½Ã¼³Àº ÃÖ°í ¼öÁØÀ̸ç, ¸ðµç »ç¶÷µéÀº ¾Æ´ÏÁö¸¸ ¸¹Àº »ç¶÷µé¿¡°Ô ÀÇ·á ºñ¿ëÀ» Àú·ÅÇÏ°Ô ¸¸µå´Â À¯¸®ÇÑ ±ÔÁ¦°¡ ÀÖÀ¸¹Ç·Î ¸¹Àº »ç¶÷µéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¶§¹®¿¡ ±¹°¡ Àüü ÆÇ¸ÅÀ²ÀÌ ³ô½À´Ï´Ù. ¶ÇÇÑ ÀÌ Áö¿ªÀÇ ½º¸¶Æ® ÀÇ·á±â±â ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇÑ ¹è°æ¿¡´Â ±â¼ú °³Ã´°ú ÃֽŠÀÇ·á±â±âÀÇ Á¶±â ¼ö¿ëÀÌ ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº ȯÀÚ°¡ ¸¹°í âÀÇÀûÀÎ Á¦Á¶¾÷üµéÀÌ Àú·ÅÇÑ ºñ¿ëÀ¸·Î ¿µ¸®ÇÑ ¼Ö·ç¼ÇÀ» ºÎºÐÀûÀ¸·Î ½ÃÀå¿¡ Á¦°øÇϰí ÀÖÀ¸¹Ç·Î ¿¹Ãø ±â°£ Áß À¯¸®ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î ÀεµÀÇ Á¦Á¶¾÷üÀÎ Ten3T Healthcare Pvt. Ltd.´Â ½ÉÀüµµ, ½É¹Ú¼ö, Ç÷Áß »ê¼Ò ³óµµ, ü¿Â µîÀÇ ÁöÇ¥¸¦ ½Ç½Ã°£À¸·Î ±â·ÏÇÒ ¼ö ÀÖ´Â ¿þ¾î·¯ºí ¸ð´ÏÅ͸µ ÀåºñÀÎ Cicer¸¦ Àú·ÅÇÑ ºñ¿ëÀ¸·Î °³¹ßÇß½À´Ï´Ù. ¶ÇÇÑ Áß±¹, ÀϺ» µî ½ÅÈï ±¹°¡ÀÇ °æÁ¦ »óȲµµ °³¼±µÇ°í ÀÖ½À´Ï´Ù. Àα¸ Áõ°¡, °¡Ã³ºÐ ¼Òµæ Áõ°¡¿¡ µû¸¥ »ýȰ ¼öÁØ Çâ»ó, ±â¼úÀûÀ¸·Î Áøº¸µÈ ½ÅÁ¦Ç°¿¡ ´ëÇÑ ¿å±¸ µîÀÌ ÀÌ Áö¿ªÀÇ ½º¸¶Æ® ÀÇ·á±â±â ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.
Omron Ventures Co., Ltd.´Â 2022³â 6¿ù, ¼¼°è ÃÖÃÊÀÇ ÀÏȸ¿ë ÈÞ´ë¿ë PCR °Ë»ç Àåºñ¸¦ °³¹ß ¹× ÆÇ¸ÅÇÏ´Â ºñ½ººñ ¸ÞµðÄÃ(Visby Medical, Inc.)¿¡ ´ëÇÑ ÅõÀÚ¸¦ ¹ßÇ¥ÇÕ´Ï´Ù.
Áö³ 6¿ù, ÄɾÄÉÀÌÇÁ Ç÷§ÆûÀÇ ±â¼ú ÅëÇÕÀÌ FDA ½ÂÀΰú CE ¸¶Å© ½ÂÀÎÀ» ¹ÞÀ½À¸·Î½á ¸ÞµåÆ®·Î´ÐÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â¼ú ¼¼Æ®°¡ ¿Ï¼ºµÇ¾ú½À´Ï´Ù. ÀÌ ÅëÇÕ ¼Ö·ç¼Ç¿¡´Â GE Healthcare FlexAcuityµµ Æ÷ÇԵǾî ÀÖÀ¸¸ç, ¼¼°è ÀÓ»óÀǵéÀÌ È¯ÀÚÀÇ ±Þ¼º±â Çʿ信 µû¶ó Ä¡·á ¿É¼ÇÀ» ¼±ÅÃÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ȯÀÚÀÇ °Ç° ¾Çȸ¦ °¡´ÉÇÑ ÇÑ Á¶±â¿¡ ¹ß°ßÇÏ´Â ¸ñÇ¥¸¦ Áö¿øÇÕ´Ï´Ù.
2021³â 5¿ù, GOQii´Â SpO2¿Í Ç÷¾Ð ¸ð´ÏÅ͸¦ °®Ãá ÃֽŠÇÇÆ®´Ï½º ¹êµå GOQii Vital 4¸¦ Ãâ½ÃÇß½À´Ï´Ù.
2021³â 1¿ù, Facedrive Health´Â V2 TraceSCAN ¿þ¾î·¯ºí ±â±âÀÎ TraceSCAN V2¸¦ Ãâ½ÃÇß½À´Ï´Ù. TraceSCAN V2´Â °³ÀÎ Á¤º¸ º¸È£ °í·Á »çÇ×, Á¤È®¼º, µ¥ÀÌÅÍ °ü¸®, ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â´É µî ÀϹÝÀûÀÎ ºí·çÅõ½º µð¹ÙÀ̽º(GPS ±â¹ÝÀÌ ¾Æ´Ô)ÀÇ ÀϹÝÀûÀÎ ´ÜÁ¡À» °³¼±ÇÏ´Â µ¿½Ã¿¡ ÁÖ¿ä °Ç° ¹× ¾ÈÀü ÀÌÁ¡À» Á¦°øÇÏ´Â ±¤¹üÀ§ÇÑ °³¼±µÈ ±â´ÉÀ» °®Ãß°í ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Smart Medical Devices Market is accounted for $46.9 billion in 2023 and is expected to reach $188.6 billion by 2030 growing at a CAGR of 22.0% during the forecast period. Wearables, helps to connect patients to doctors by delivering important medical data in real time from hospital beds and private residences, as well as mobile technology used at emergency sites and in transport vehicles. Despite the fact that patient data was collected long before the emergence of smart technology, the deployment of smart medical devices has enabled healthcare professionals to collect patient data.
According to the United Nations Population Fund, the region contributes to over 4.3 billion of the global population. According to American Heart Association 2021, heart disease and Stroke Statistics Update fact Sheet, Coronary Heart Disease (CHD) was the leading cause (42.1%) of deaths attributable to cardiovascular disease in the United States.
Growing market investments also help the sector build a stronger growth trajectory. Massive changes are taking place in the healthcare sector, many of which are positive. One of the most significant and beneficial consequences stated here is technological advancement. The potential benefits are immense, and this abundance is driving up demand for smart medical devices that go even further in efforts to enhance healthcare outcomes.
The lack of appropriate electrical infrastructure in developing and low-income nations is hindering the growth of the smart medical device market. Because modern medical devices rely heavily on electricity-powered IT hardware and software, developing countries are unable to integrate smart medical devices without impacting healthcare operations. As a result, a power outage or a limited supply of electricity endangers the operation of smart devices.
The prevalence of chronic diseases is rapidly increasing. As this development can be linked to a variety of lifestyle changes. One of these is a lack of exercise, poor eating habits, smoking, drinking, and other unhealthy habits. In addition, significantly elevated stress levels are a factor in a variety of health conditions. Additionally, chronic illnesses are highly common in the United States, a developed country with a strong healthcare system and favorable payment policies. Another factor boosting the global market for smart medical devices is the growing fitness trend. The need for smart medical devices grows as more people engage in physical activity for health reasons, such as running and sports, driving the use of medical devices.
The high cost of smart medical devices is due to their greater technological capabilities. Most middle- and lower-income people cannot afford these technologies, making them inaccessible to them. The high cost of smart medical devices may limit the market's growth over the forecast period. However, privacy issues will further limit the market growth.
The COVID-19 pandemic has had a positive impact on the smart medical device enterprise. With the introduction of the coronavirus, many community centers and other fitness organizations in most parts of the world became inactive. Users were urged to use digital and other app-based solutions as a result of this. Furthermore, rising awareness and preference for AI-based medical equipment that aids in tracking and monitoring human vital signs are expected to drive market expansion. In India, for instance, Max Healthcare and MyHealthcare will launch an AI-based device connected with patient monitoring systems in June 2021.
The therapeutic device segment is expected to have the largest market share throughout the forecast period because an insulin pump is a medical device that provides insulin to diabetic patients. The insulin pump is made up of three parts: a pump, a disposable reservoir, and a disposable infusion set. The pump component is made up of controllers, a processing module, and batteries. Inside the pump, the disposable reservoir stores the insulin. However, a cannula and a tubing system to connect the insulin reservoir to the cannula comprise the disposable infusion set. Insulin pumps are portable and measure the exact amount of insulin to be supplied, reducing dosage waste and ensuring correct insulin delivery to patients.
The cardiovascular category is expected to develop at the highest rate of CAGR throughout the forecast period due to an increase in cardiovascular disease incidents such as diabetes and a surge in medical device research spending. Furthermore, the increased use of smart medical devices has contributed to an increase in demand for device applications, propelling market growth. Additionally, the demand for cardiovascular devices is expected to rise due to an increase in the aging population, technological improvements, and the efficacy of smart medical devices.
Regionally, North America has the largest share of the market and will continue to do so during the forecast period. North American healthcare facilities are of the highest standard and are available to a broad population due to favorable regulations that make healthcare inexpensive for many, if not all, people. This contributes to a higher selling rate across the country. Furthermore, the considerable expansion of this region's smart medical device market has been driven by technological developments and the early acceptance of modern medical equipment.
Because of a large pool of patients and creative manufacturers bringing clever solutions to the market at partially cheaper costs, Asia Pacific region is projected to witness lucrative growth throughout the extrapolated period. Ten3T Healthcare Pvt. Ltd., an Indian manufacturer, for instance, created Cicer, a wearable monitoring device capable of recording ECG and other indications such as heart rate, blood oxygen, and temperature in real-time at a low cost. Additionally, the economic conditions of emerging economies like China and Japan have improved. The increasing population, rising living standards as disposable income rises, and a desire for new technologically advanced products have all boosted the demand for smart medical devices in the region.
Some of the key players in Smart Medical Devices market include Samsung, Vital Connect, Koninklijke Philips N.V., Otsuka Holdings CO. LTD, Omron Corporation, NeuroMetrix Inc., Medtronic PLC, Fitbit Inc., F. Hoffmann-La Roche Ltd, Dexcom Inc., BIO-BEAT, Apple Inc. and Abbott Laboratories.
In June 2022, Omron Ventures Co., Ltd. is pleased to announce an investment in Visby Medical, Inc., a company that develops and sells the world's first disposable portable PCR testing devices.
In June 2022, The integration of the technologies on the Carescape platform has received FDA clearance and CE mark approval, completing the system's full suite of Medtronic patient monitoring technologies. The combined solution also includes GE Healthcare FlexAcuity, which enables clinicians globally to select care options based on patient acuity needs, and assists them in their goal of detecting patient health deterioration as early as possible.
In May 2021, GOQii launched GOQii Vital 4, the latest fitness band with a SpO2 and blood pressure monitor, and tracks all-day activity like steps, distance, and the calories burned.
In January 2021, Facedrive Health launched V2 TraceSCAN Wearable Device. TraceSCAN V2 features an extensive set of improved functionalities to offer key health and safety advantages while enhancing the usual shortcomings of typical Bluetooth devices (which are not GPS-based), such as privacy considerations, accuracy, data management, and vital signs monitoring capability.